![Jeffrey Edwards](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Edwards
Director/Board Member at
KYNTRA BIO, INC.
Net worth: 241 864 $ as of 2026-07-30
Profile
Mr. Jeffrey L.
Edwards is an Independent Director at Clearside Biomedical, Inc., an Independent Director at Bio-Rad Laboratories, Inc., an Independent Director at Kyntra Bio, Inc., a Chief Financial Officer, Director & Vice President at Serica Technologies, Inc. and an Independent Director at Viamet Pharmaceuticals Corp.
He is on the Board of Directors at Clearside Biomedical, Inc., Bio-Rad Laboratories, Inc., Kyntra Bio, Inc., MAP Pharmaceuticals LLC, Serica Technologies, Inc., Viamet Pharmaceuticals, Inc. and Viamet Pharmaceuticals Corp.
Mr. Edwards was previously employed as an Independent Director by Lifecore Biomedical, Inc., a Chief Financial Officer & Executive VP-Finance by Allergan, Inc., a Principal by Banque Paribas Belgique SA, and a Principal by Security Pacific National Bank.
He also served on the board at BioTheryX, Inc. He received his undergraduate degree from Muhlenberg College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-20 | 715 ( 0% ) | 232 718 $ | 2026-07-30 | |
KYNTRA BIO, INC. 0.03% | 2026-06-11 | 1,359 ( 0.03% ) | 9 146 $ | 2026-07-30 |
Jeffrey Edwards active positions
| Companies | Position | Start |
|---|---|---|
| KYNTRA BIO, INC. | Director/Board Member | 2015-10-27 |
| BIO-RAD LABORATORIES, INC. | Director/Board Member | 2017-04-24 |
| CLEARSIDE BIOMEDICAL | Director/Board Member | 2018-09-25 |
Serica Technologies, Inc.
 Serica Technologies, Inc. Pharmaceuticals: MajorHealth Technology Distributes silk based biomaterial products for tissue rejuvenation | Director of Finance/CFO | 2011-04-24 |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Director/Board Member | 2013-02-28 |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Director/Board Member | - |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Director/Board Member | - |
Former positions of Jeffrey Edwards
| Companies | Position | End |
|---|---|---|
| LIFECORE BIOMEDICAL, INC. | Director/Board Member | 2024-09-22 |
BioTheryX, Inc.
 BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Director/Board Member | 2021-04-30 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Jeffrey Edwards
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
77
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bio-Rad Laboratories, Inc.
 Bio-Rad Laboratories, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes life science research products & clinical diagnostics | Health Technology |
Lifecore Biomedical, Inc.
 Lifecore Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Develops and sells sterile injectable pharmaceutical products | Health Technology |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Health Technology |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Health Technology |
Serica Technologies, Inc.
Serica Technologies, Inc. Pharmaceuticals: MajorHealth Technology Distributes silk based biomaterial products for tissue rejuvenation | Health Technology |
BioTheryX, Inc.
BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Technology Services |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Health Technology |
Banque Paribas Belgique SA
 Banque Paribas Belgique SA Regional BanksFinance A commercial bank | Finance |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
Muhlenberg College
 Muhlenberg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Security Pacific National Bank
 Security Pacific National Bank Major BanksFinance National bank | Finance |
Clearside Biomedical, Inc.
 Clearside Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures suprachoroidal space injections for eye diseases | Health Technology |
- Stock Market
- Insiders
- Jeffrey Edwards
